Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identifying therapeutic target genes for migraine by systematic druggable genome-wide Mendelian randomization.

The journal of headache and pain - 12 Jun 2024

Zhang Chengcheng, He Yiwei, Liu Lu

Abstract excerpt

BACKGROUND: Currently, the treatment and prevention of migraine remain highly challenging. Mendelian randomization (MR) has been widely used to explore novel therapeutic targets. Therefore, we performed a systematic druggable genome-wide MR to explore the potential therapeutic targets for migraine. METHODS: We obtained data on druggable genes and screened for genes within brain expression quantitative trait locis...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain
Share to Genetic Predisposition to Disease
Share to Genome-Wide Association Study

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mendelian Randomization Analysis

Share to Migraine Disorders

Share to Quantitative Trait Loci

Source

Open in PubMed Open full text

Identifiers

PMID: 38867170
DOI: 10.1186/s10194-024-01805-3
PMCID: PMC11167905

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identifying therapeutic target genes for migraine by systematic druggable genome-wide Mendelian randomization.PMID 38867170Read ↗

Multi-omics Mendelian randomization integrating GWAS, eQTL and pQTL data revealed GSTM4 as a potential drug target for migraine.Semantic proximity Read ↗

Proteome-wide Mendelian randomization identified potential drug targets for migraineSemantic proximity Read ↗

Identifying novel proteins for migraine by integrating proteomes from blood and CSF with genome-wide association data.Semantic proximity Read ↗

Lipids, lipid-modifying drug target genes and migraine: a Mendelian randomization studySemantic proximity Read ↗

Genome-wide Mendelian randomization identifies actionable novel drug targets for psychiatric disorders.Semantic proximity Read ↗

Mendelian Randomization Using the Druggable Genome Reveals Genetically Supported Drug Targets for Psychiatric Disorders.Semantic proximity Read ↗

Identifying causal genes for migraine by integrating the proteome and transcriptomeSemantic proximity Read ↗

Exploring Migraine Pathogenesis: Transcriptomic Insights and Pathway Analysis in Nitroglycerin-Induced Rat ModelSemantic proximity Read ↗

Identification of comorbid genes between type 2 diabetes and migraine through peripheral blood single-cell and Mendelian randomization analysisSemantic proximity Read ↗

HMG-CoA reductase is a potential therapeutic target for migraine: a mendelian randomization study.Semantic proximity Read ↗

Genetics of migraine.Semantic proximity Read ↗

Mendelian randomization and colocalization analysis reveal novel drug targets for myasthenia gravis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.